Quantum Biopharma (QNTM) Cash & Current Investments (2018 - 2026)

Quantum Biopharma (QNTM) has 9 years of Cash & Current Investments data on file, last reported at $4.6 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 28.98% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (up 28.98% YoY), and the FY2025 full-year result was $2.4 million, down 67.15% from the prior year.
• Cash & Current Investments improved to $4.6 million in Q1 2026, from $2.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $32.0 million in Q2 2022 to a low of $1.1 million in Q3 2025.
• A 5-year average of $10.2 million and a median of $6.2 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments jumped 51.04% in 2024 and slumped 83.61% in 2025, its largest moves.
• Tracing QNTM's Cash & Current Investments over 5 years: stood at $17.0 million in 2022, then plunged by 74.24% to $4.4 million in 2023, then jumped by 64.59% to $7.2 million in 2024, then tumbled by 67.15% to $2.4 million in 2025, then surged by 93.06% to $4.6 million in 2026.
• Business Quant data shows QNTM's Cash & Current Investments at $4.6 million in Q1 2026, $2.4 million in Q4 2025, and $1.1 million in Q3 2025.